Withdrawal of a medicinal product from sale | Be careful if you use it, it is best to contact your doctor

I encountered the first problems last month. There are many lots that have been voluntarily withdrawn by the company. This is what happens

It was a valuable property. And what’s more, it is widely used. But now it can become a nightmare for many. If you have taken it, we advise you to seek immediate medical attention as the consequences can be very serious.

Pfizer (web source)

It’s real estate It is widely used because it is known to have beneficial effects on high blood pressure. And as we know, there are a lot of people with high blood pressure who need constant care so they don’t have more problems.

It I had a problem For the first time last month and covered by Five batches of cereal each containing 90 bottles. was the medicine withdrawn Because The presence of nitrosamines is above average.

What is it exactly? Nitrosamines are common in water and foods, including grilled meats, dairy products, and vegetables.. Everyone is exposed to some level of nitrosamines. This bug can Increase the risk of cancer If people are exposed to it above acceptable levels for extended periods of time.

The lottery has been drawn

Pfizer voluntarily withdraws five payments from acupril It is distributed to patients due to the presence of a nitrosamine, nitrosoquinapril, which has been observed in recent tests above the acceptable daily dose.

Acupril is indicated for the treatment of hypertension, to lower blood pressure. Accupril is also indicated in the management of heart failure as an adjuvant therapy when added to conventional therapy comprising diuretics and/or digitalis.

Accupril has had a consistent safety profile for more than 30 years. So, the news came like a thunderbolt out of the blue. To date, however, Pfizer is not aware of any adverse event reports believed to be related to this recall.

Accupril (web source) 04.26.2022 direttanews.it
Accupril (web source)

Pfizer believes that the benefits/risks of the products remain positive based on the data currently available. Although long-term use of Nnitroso-quinapril may be associated with an increased risk of cancer in humans, there is no immediate risk to patients taking this drug.

Patients currently taking the products should consult their physician or healthcare provider about their alternative treatment options.

However, it must be said that the drugs did not interest Italy, since they were distributed in the United States and Puerto Rico.

Leave a Comment